Megan Quintas

A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study

William O’Riordan, Alison J. McManus, Jüri Teras et al. · Clinical Infectious Diseases · 2018 · 105 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A Phase-3 Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults with Community-acquired Bacterial Pneumonia (DEFINE-CABP)

Juan Pablo Horcajada, Robert A. Salata, Rodolfo Álvarez-Sala et al. · Open Forum Infectious Diseases · 2019 · 52 citations · Full text

Medicine, Infectious Diseases, Pharmacology +14

Clinical Pharmacokinetics of Sulfobutylether‐β‐Cyclodextrin in Patients With Varying Degrees of Renal Impairment

Randall Hoover, Harry Alcorn, Laura Lawrence et al. · The Journal of Clinical Pharmacology · 2018 · 36 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment

Randall Hoover, Thomas Marbury, Richard A. Preston et al. · The Journal of Clinical Pharmacology · 2016 · 35 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial

Sandra P. McCurdy, Kara Keedy, Laura Lawrence et al. · Antimicrobial Agents and Chemotherapy · 2019 · 34 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17